As of 2025-07-15, the Relative Valuation of Seelos Therapeutics Inc (SEEL) is 1,023.73 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.28 USD, the upside of Seelos Therapeutics Inc based on Relative Valuation is 79879.1%.
The range of the Relative Valuation is 947.80 - 1,172.97 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 19.1x | 18.5x |
| Forward P/E multiples | 19.4x - 22.4x | 20.6x |
| Fair Price | 947.80 - 1,172.97 | 1,023.73 |
| Upside | 73947.1% - 91538.4% | 79879.1% |
| Date | P/E |